SCHEMBL1868690

SCHEMBL1868690

CCCn1c(Oc2cccnc2C)nc(=O)c2c1N=C(C1CCCC1)[N]2

nearest known ligand 0.57

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 10/20 0.57
ADORA2A P29274 1/20 0.57
ADORA2B P29275 1/20 0.57
CHRNB2 P17787 2/20 0.36
CHRNA4 P43681 2/20 0.36
CHRNB1 P11230 1/20 0.36
CHRNB4 P30926 1/20 0.36
CHRNA3 P32297 1/20 0.36
CHRNB3 Q05901 1/20 0.36
ADORA3 P0DMS8 1/20 0.35
GPR119 Q8TDV5 3/20 0.34
PDE1A P54750 2/20 0.33
PDE1B Q01064 2/20 0.33
PDE1C Q14123 2/20 0.33
PDE5A O76074 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1868269 0.90 ADORA1 (0.59) ADORA1ADORA2AADORA2BCHRNB2CHRNA4
SCHEMBL1871255 0.88 ADORA1 (0.46) ADORA1ADORA2AADORA2BCHRNB2CHRNA4
SCHEMBL1871420 0.87 ADORA1 (0.41) ADORA1ADORA2AADORA2BADORA3
SCHEMBL1866236 0.86 ADORA1 (0.41) ADORA1ADORA2AADORA2BADORA3
SCHEMBL1875802 0.84 ADORA1 (0.44) ADORA1ADORA2AADORA2BADORA3
SCHEMBL1875306 0.83 ADORA1 (0.56) ADORA1ADORA2AADORA2BCHRNB2CHRNA4
SCHEMBL1868066 0.82 ADORA1 (0.38) ADORA1ADORA2AADORA2BADORA3
SCHEMBL1870705 0.82 ADORA1 (0.42) ADORA1ADORA2AADORA2BCHRNB2CHRNA4
SCHEMBL1869240 0.81 ADORA1 (0.38) ADORA1ADORA2AADORA2BADORA3
SCHEMBL1864786 0.81 ADORA1 (0.39) ADORA1ADORA2AADORA2BADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2499142-A1 SUBSTITUTED FUSED PYRIMIDINE COMPOUNDS, ITS PREPARATION AND USES THEREOF Advinus Therapeutics Limited (IN) 2012-09-19 EP claimed
WO-2011055391-A1 SUBSTITUTED FUSED PYRIMIDINE COMPOUNDS, ITS PREPARATION AND USES THEREOF ADVINUS THERAPEUTICS PRIVATE LIMITED (IN) 2011-05-12 WO claimed